Immutep Ltd ( PRRUF) - Key Metrics
PRRUF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $0.01 | -$0.02 | -$0.02 | -$0.02 |
| 2026Q2 | $0 | -$0.03 | -$0.02 | -$0.02 |
| 2025Q4 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2025Q2 | $0 | -$0.02 | -$0.01 | -$0.01 |
| 2024Q4 | $0 | -$0.02 | -$0.01 | -$0.01 |
PRRUF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | -0.77 |
| 2026Q2 | 0% | -3.92 |
| 2025Q4 | 0% | -5.39 |
| 2025Q2 | 0% | -5.24 |
| 2024Q4 | 0% | -3.88 |
PRRUF
Price: $0.02
52 week price:
Earnings Per Share: -0.04 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 44.2 million